Document Detail

Primary retroperitoneal choriocarcinoma with pulmonary metastases in an elderly man.
MedLine Citation:
PMID:  2237390     Owner:  NLM     Status:  MEDLINE    
We describe a 56-year old male smoker who presented with bilateral gynaecomastia and a large shadow in the upper zone of the right lung. Lobectomy revealed a haemorrhagic tumour at the apex of the right upper lobe. Histology revealed pure choriocarcinoma. Further investigations revealed normal testes and a retroperitoneal mass. Apart from histology, the other poor prognostic factors in this patient were the extragonadal site, gynaecomastia and age. Complete remission was achieved with an aggressive 5-day chemotherapy regime. Primary retroperitoneal choriocarcinoma is extremely rare and is predominantly seen in the age group between 20-30 years.
V Raina; D J Dunlop; M Soukop
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Scottish medical journal     Volume:  35     ISSN:  0036-9330     ISO Abbreviation:  Scott Med J     Publication Date:  1990 Aug 
Date Detail:
Created Date:  1990-12-07     Completed Date:  1990-12-07     Revised Date:  2006-04-24    
Medline Journal Info:
Nlm Unique ID:  2983335R     Medline TA:  Scott Med J     Country:  SCOTLAND    
Other Details:
Languages:  eng     Pagination:  116     Citation Subset:  IM    
Department of Medical Oncology, Royal Infirmary, Glasgow.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Choriocarcinoma / diagnosis*,  drug therapy,  secondary
Lung Neoplasms / diagnosis,  drug therapy,  secondary*
Middle Aged
Remission Induction
Retroperitoneal Neoplasms / diagnosis*,  drug therapy
Tomography, X-Ray Computed

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical and biochemical pregnancy in two respective recipients without ovarian function following g...
Next Document:  A short history of medical degrees in the University of Aberdeen.